Elanco Animal Health Incorporated (NYSE: ELAN) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $12.9B. The Maz Rating grades it against the other companies in its sector.
Elanco Animal Health Incorporated's current Maz Rating and its five factor grades are for members: log in to see them.
At $25.85, Elanco Animal Health Incorporated trades at 2.5x sales and 2.0x book value, with an EV/EBITDA of 23.9. Over the last twelve months it generated about $5.1B of revenue and a net loss of $149M. It runs a gross margin of 53.5%, an operating margin of 10.0% and a net margin of -2.9%. It shows return on equity of -2.2%, return on invested capital of 4.4% and a free cash flow yield of 3.1%. On the balance sheet: a debt-to-equity ratio of 0.56 and a current ratio of 2.09. Over the past 52 weeks the share price ranged from $19.40 to $27.98, with a beta of 1.72.
Elanco Animal Health Incorporated does not currently pay a dividend.
22 Wall Street analyst ratings cover the stock: 15 Buy, 5 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.